Theodore Schroeder
2018
In 2018, Theodore Schroeder earned a total compensation of $2.5M as Chief Executive Officer at Nabriva Therapeutics AG.
Compensation breakdown
| Option Awards | $1,739,100 |
|---|---|
| Salary | $220,360 |
| Stock Awards | $529,500 |
| Other | $20,380 |
| Total | $2,509,340 |
Schroeder received $1.7M in option awards, accounting for 69% of the total pay in 2018.
Schroeder also received $220.4K in salary, $529.5K in stock awards and $20.4K in other compensation.
Rankings
In 2018, Theodore Schroeder's compensation ranked 4,645th out of 14,244 executives tracked by ExecPay. In other words, Schroeder earned more than 67.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,645 out of 14,244 | 67th |
Division Manufacturing | 1,747 out of 5,759 | 70th |
Major group Chemicals And Allied Products | 630 out of 2,122 | 70th |
Industry group Drugs | 528 out of 1,811 | 71st |
Industry Pharmaceutical Preparations | 408 out of 1,385 | 71st |
Source: SEC filing on June 14, 2019.
Schroeder's colleagues
We found three more compensation records of executives who worked with Theodore Schroeder at Nabriva Therapeutics AG in 2018.